Efficacy and safety of ensitrelvir in patients with mild-to-moderate COVID-19: the phase 2b part of a randomized, placebo-controlled, phase 2/3 study
Mukae et al., Clinical Infectious Diseases, doi:10.1093/cid/ciac933
https://c19early.org/mukae3.html